Liquid Biopsy Following BBB Disruption Using Barrier Disrupting Fields in Patients Undergoing Spine Surgery
NCT07224451 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-11-04
Summary
Objective: To identify new central nervous system (CNS) biomarkers to be used for blood-derived liquid biopsy once the blood-brain barrier (BBB), specifically the blood-arachnoid barrier (BAB), has been transiently disrupted by BDF in patients undergoing spine surgery.
Design: Single center (Sheba Medical Center), prospective, controlled. Phase: Feasibility study
Endpoints:
Efficacy The primary endpoint of the study is the elevation in blood concentration of CNS biomarkers following the study procedure compared to biomarkers detected in cerebrospinal fluid (CSF) of the same subject.
Safety The primary safety endpoint will be the overall incidence of BDF procedure-related AEs and SAEs, with severity graded according to CTCAE v5.0 criteria.
Study population:
The study population will include up to 20 patients undergoing spine surgery.
Study period:
24 months.
Inclusion criteria:
1. Adult subjects over the age of 18
2. Able to sign informed consent
3. Candidates for intradural tumor resection spinal surgery with intraoperative neuromonitoring.
Exclusion criteria:
1. Pacemakers, or other implanted electric medical devices
2. Pregnant or lactating females
3. Major medical, neurologic or psychiatric condition who are judged as unable to fully comply with the study
4. History of skull fractures or previous brain surgery
5. American Society of Anesthesiologists grade \>2
6. Anticoagulants treatment
7. Damage to the dura resulting in CSF leak
8. Patients with seizures/epilepsy
Study procedure:
1. Candidates for intradural tumor resection spinal surgery with intraoperative neuromonitoring will be enrolled in the study prior to surgery.
2. The patient will undergo preparation for surgery according to the standard care.
3. Once anesthetized and intubated, electrodes will be attached to the patient's head.
4. After placing the electrodes, when the patient is under anesthesia, a blood sample will be taken prior to BDF. This sample will be used as baseline for BDF.
5. The patient will then undergo a BDF procedure.
6. Additional blood samples will be taken for identification of CNS biomarkers.
7. Surgery will then proceed according to the standard of care.
8. Once the dura is opened, a CSF sample will be taken, in order to compare the blood biomarkers of the specific subject with the CSF biomarkers.
9. The surgery will continue according to the standard of care.
Conditions
- Spinal Tumors
Interventions
- PROCEDURE
-
spinal surgery
Candidates for intradural tumor resection spinal surgery with intraoperative neuromonitoring will be enrolled in the study prior to surgery. The patient will undergo preparation for surgery according to the standard care. Once anesthetized and intubated, electrodes will be attached to the patient's head. After placing the electrodes, when the patient is under anesthesia, a blood sample will be taken prior to BDF. This sample will be used as baseline for BDF. The patient will then undergo a BDF procedure. Additional blood samples will be taken for identification of CNS biomarkers. Surgery will then proceed according to the standard of care. Once the dura is opened, a CSF sample will be taken. The surgery will continue according to the standard of care
- DEVICE
-
BDF
electrodes couples (voltage and ground) will be placed on the patient head and will be connected to a pulse generator. 2 electrodes couples will be activated in parallel, up to 8 electrodes couples total. EEG will be acquired after each series of pulses for a few sec.
Sponsors & Collaborators
-
Sheba Medical Center
lead OTHER_GOV
Principal Investigators
-
Ran Harel, MD · Sheba Medical Center
-
Yael Mardor, PhD · Sheba Medical Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-16
- Primary Completion
- 2027-10-31
- Completion
- 2027-10-31
- FDA Device
- Yes
Countries
- Israel
Study Locations
More Related Trials
-
Injection of Autologous Bone Marrow Aspirate in Patients With Degenerative Disc Disease.
NCT05146583 ·Status: UNKNOWN
-
New Robotic Assistance System for Spinal Fusion Surgery
NCT02558621 ·Status: COMPLETED ·Phase: NA
-
Lumbar & Sacroiliac Fusion Study Involving Previously Implanted Devices
NCT07204288 ·Status: RECRUITING ·Phase: NA
-
Lumbar Interbody Implant Study
NCT04418830 ·Status: ENROLLING_BY_INVITATION
-
Assessing Safety of Cervical Spine Fusion With NMP®
NCT07245940 ·Status: NOT_YET_RECRUITING
-
Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine Surgery
NCT04563806 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
NCT03100032 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
NCT06000319 ·Status: ENROLLING_BY_INVITATION
-
Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI
NCT05018793 ·Status: RECRUITING ·Phase: PHASE1
-
PRP Spinoplasty for Chronic Low Back Pain With Multiple Pathologies: A Quasi-Experimental Study
NCT07268885 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of the Neuro-Spinal Scaffold for the Treatment of AIS A Cervical Acute SCI
NCT03105882 ·Status: WITHDRAWN ·Phase: NA
-
Fluoroscopically-guided Epidural Block in the Midthoracic Region: A Comparison of Anterioposterior Versus Oblique View Approach
NCT02300714 ·Status: TERMINATED ·Phase: NA
-
Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine
NCT02023372 ·Status: COMPLETED ·Phase: NA
-
Identifying Biomarkers and Changes in Cerebrospinal Fluid Collected Pre and Post Spinal Cord Stimulation in Subjects Suffering From Chronic Refractory Pain Conditions
NCT03986255 ·Status: TERMINATED ·Phase: NA
-
Combining Intraoperative Radiotherapy With Kyphoplasty for Treatment of Spinal Metastases
NCT02480036 ·Status: UNKNOWN ·Phase: PHASE1
-
Tractography and Diffusion Tensor Imaging of the Human Spinal Cord in Healthy Subjects : Anatomical Atlas
NCT05079945 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Safety and Effectiveness of Spinal Sealant
NCT00594035 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Remote Preconditioning in Patients Undergoing Cervical Decompression Surgery
NCT00778323 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Spine Oncology Registry
NCT07225491 ·Status: RECRUITING
-
Study Comparing Conventional, Burst and High Frequency (HF) Spinal Cord Stimulation (SCS) in Refractory Failed Back Surgery Syndrome (FBSS) Patients After a 32-contact Surgical Lead Implantation
NCT03014583 ·Status: COMPLETED ·Phase: NA
-
Intra-Operative Dural Brachytherapy With Yttrium-90 Plaque Applicators
NCT00706485 ·Status: TERMINATED ·Phase: NA
-
Stereotactic Radiosurgery in Metastatic Spinal Cord Compression
NCT02167633 ·Status: TERMINATED ·Phase: NA
-
Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain
NCT01290367 ·Status: COMPLETED ·Phase: PHASE2
-
Robotic Assisted Vertebral Body Augmentation - a Radiation Reduction Tool
NCT01269359 ·Status: UNKNOWN
-
Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome
NCT03444168 ·Status: COMPLETED